Amgen and Kyowa Kirin agreed to end their rocatinlimab collaboration on Jan. 30, 2026; the split only becomes effective upon regulatory approval and shifts global responsibilities to Kyowa Kirin.
FG Nexus says an industry study ranked it #1 by median SPAC returns; the recognition boosts its repeat-sponsor pitch as it builds a digital-asset treasury.
VinFast delivered 86,557 EVs in 4Q25 and 196,919 for full-year 2025; numbers are preliminary and don’t automatically equal revenue.
Bluejay (BJDX) shrank its share base to roughly 708k via a 1-for-4 reverse split; warrants and awards were adjusted and trading continued under BJDX.
AstraZeneca (AZN) struck a deal to acquire rights to CSPC’s once-monthly injectables, including SYH2082, paying $1.2B upfront and gaining AI and LiquidGel tech.
HUHUTECH (HUHU) shareholders gave the board a two-year green light to consolidate shares between 2-for-1 and 8,000-for-1, with rounding and charter updates tied to the move.
Augury
